Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16354 | 593 | 33.5 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2066 | 4824 | BRONCHIECTASIS//PRIMARY CILIARY DYSKINESIA//MUCOCILIARY CLEARANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RHDNASE | Author keyword | 32 | 63% | 5% | 32 |
2 | DORNASE ALFA | Author keyword | 18 | 53% | 4% | 23 |
3 | MUCUS VISCOELASTICITY | Author keyword | 15 | 88% | 1% | 7 |
4 | MUCUS PENETRATING PARTICLES | Author keyword | 13 | 67% | 2% | 12 |
5 | MUCUS RHEOLOGY | Author keyword | 10 | 63% | 2% | 10 |
6 | HERITAGE MED 173 | Address | 9 | 83% | 1% | 5 |
7 | RECOMBINANT HUMAN DNASE | Author keyword | 8 | 62% | 1% | 8 |
8 | RECOMBINANT HUMAN DEOXYRIBONUCLEASE | Author keyword | 7 | 67% | 1% | 6 |
9 | INHALED MANNITOL | Author keyword | 6 | 80% | 1% | 4 |
10 | MUCOCILIARY CLEARANCE | Author keyword | 6 | 11% | 8% | 49 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RHDNASE | 32 | 63% | 5% | 32 | Search RHDNASE | Search RHDNASE |
2 | DORNASE ALFA | 18 | 53% | 4% | 23 | Search DORNASE+ALFA | Search DORNASE+ALFA |
3 | MUCUS VISCOELASTICITY | 15 | 88% | 1% | 7 | Search MUCUS+VISCOELASTICITY | Search MUCUS+VISCOELASTICITY |
4 | MUCUS PENETRATING PARTICLES | 13 | 67% | 2% | 12 | Search MUCUS+PENETRATING+PARTICLES | Search MUCUS+PENETRATING+PARTICLES |
5 | MUCUS RHEOLOGY | 10 | 63% | 2% | 10 | Search MUCUS+RHEOLOGY | Search MUCUS+RHEOLOGY |
6 | RECOMBINANT HUMAN DNASE | 8 | 62% | 1% | 8 | Search RECOMBINANT+HUMAN+DNASE | Search RECOMBINANT+HUMAN+DNASE |
7 | RECOMBINANT HUMAN DEOXYRIBONUCLEASE | 7 | 67% | 1% | 6 | Search RECOMBINANT+HUMAN+DEOXYRIBONUCLEASE | Search RECOMBINANT+HUMAN+DEOXYRIBONUCLEASE |
8 | INHALED MANNITOL | 6 | 80% | 1% | 4 | Search INHALED+MANNITOL | Search INHALED+MANNITOL |
9 | MUCOCILIARY CLEARANCE | 6 | 11% | 8% | 49 | Search MUCOCILIARY+CLEARANCE | Search MUCOCILIARY+CLEARANCE |
10 | COUGH CLEARANCE | 5 | 63% | 1% | 5 | Search COUGH+CLEARANCE | Search COUGH+CLEARANCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN DEOXYRIBONUCLEASE | 63 | 83% | 6% | 35 |
2 | RECOMBINANT HUMAN DNASE | 36 | 35% | 14% | 84 |
3 | SIMULATED COUGH | 18 | 59% | 3% | 20 |
4 | RHDNASE | 16 | 54% | 3% | 20 |
5 | HYPERTONIC SALINE AEROSOL | 10 | 61% | 2% | 11 |
6 | RESPIRATORY MUCUS | 9 | 39% | 3% | 18 |
7 | HUMAN DNASE I | 9 | 36% | 3% | 20 |
8 | DRY POWDER MANNITOL | 9 | 40% | 3% | 17 |
9 | CYSTIC FIBROSIS SPUTUM | 8 | 21% | 5% | 32 |
10 | MUCUS CLEARANCE | 8 | 21% | 5% | 32 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mucus as a Barrier to Drug Delivery - Understanding and Mimicking the Barrier Properties | 2015 | 3 | 43 | 47% |
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers | 2012 | 131 | 122 | 16% |
Dornase alfa for cystic fibrosis | 2010 | 32 | 46 | 72% |
Mucus as a barrier to lipophilic drugs | 2013 | 16 | 115 | 32% |
Dornase Alfa for Non-Cystic Fibrosis Pediatric Pulmonary Atelectasis | 2014 | 1 | 21 | 81% |
Effect of inhaled dry powder mannitol on mucus and its clearance | 2013 | 6 | 75 | 53% |
Nebulised hypertonic saline for cystic fibrosis | 2009 | 32 | 17 | 82% |
Drug transfer through mucus | 2001 | 128 | 69 | 32% |
Micro- and macrorheology of mucus | 2009 | 129 | 147 | 33% |
Timing of dornase alfa inhalation for cystic fibrosis | 2011 | 5 | 47 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HERITAGE MED 173 | 9 | 83% | 0.8% | 5 |
2 | JOHNS HOPKINS ADULT CYST FIBROSIS PROGRAM | 3 | 45% | 0.8% | 5 |
3 | CANC NANOTECHNOL EXCELLENCE | 2 | 20% | 1.9% | 11 |
4 | PULM DEF GRP | 2 | 67% | 0.3% | 2 |
5 | LIM 05 | 2 | 43% | 0.5% | 3 |
6 | CF OUTPATIENT CLIN | 1 | 100% | 0.3% | 2 |
7 | LIM 34 | 1 | 50% | 0.3% | 2 |
8 | CEPREA 6305 | 1 | 50% | 0.2% | 1 |
9 | DISTBIF | 1 | 50% | 0.2% | 1 |
10 | GRP PNEUMOL IMAGERIE CIBLAGE | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000198787 | JOURNAL OF CYSTIC FIBROSIS//INHALED TOBRAMYCIN//PULMONARY EXACERBATION |
2 | 0.0000167311 | CHEST PHYSIOTHERAPY//ENDOTRACHEAL SUCTIONING//AUTOGENIC DRAINAGE |
3 | 0.0000162237 | ERDOSTEINE//FUDOSTEINE//S CARBOXYMETHYL L CYSTEINE |
4 | 0.0000145135 | PRIMARY CILIARY DYSKINESIA//CILIARY BEAT FREQUENCY//KARTAGENER SYNDROME |
5 | 0.0000133810 | BRONCHIECTASIS//MIDDLE LOBE SYNDROME//GUANGZHOU P DISAFFILIATED HOSP 1 |
6 | 0.0000130880 | PLASTIC BRONCHITIS//BRONCHIAL CASTS//CAST BRONCHITIS |
7 | 0.0000114974 | GENE MED GRP//GENEMED GRP//EXPT TREATMENT CYST FIBROSIS |
8 | 0.0000107693 | MUC4//MUCIN//MUC2 |
9 | 0.0000097518 | MUC5AC//AIRWAY MUCIN//MUC5B |
10 | 0.0000090511 | TRANSEPITHELIAL ELECTRICAL POTENTIAL DIFFERENCE//PATHOBIOCHEM CLIN CHEM//SWEAT GLAND |